Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma von Kwong, Y.L., Kim, S.J., Tse, E., Oh, S.Y., Kwak, J.Y., Eom, H.S., Do, Y.R., Mun, Y.C., Lee, S.R., Shin, H.J., Suh, C., Chuang, S.S., Lee, Y.S., Lim, S.T., Izutsu, K., Suzuki, R., Relander, T., d’Amore, F., Schmitz, N., Jaccard, A., Kim, W.S.

Volltext

Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study von Yun, Y.H., Lee, M.K., Park, S.M., Kim, Y.A., Lee, W.J., Lee, K.S., Choi, J.S., Jung, K.H., Do, Y.R., Kim, S.Y., Heo, D.S., Kim, H.T., Park, S.R.

Volltext

A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas von Kim, S.J., Shin, D.-Y., Kim, J.S., Yoon, D.H., Lee, W.S., Lee, H., Do, Y.R., Kang, H.J., Eom, H.S., Ko, Y.H., Lee, S.H., Yoo, H.Y., Hong, M., Suh, C., Kim, W.S.

Volltext

Identification of a novel PML-RARG fusion in acute promyelocytic leukemia von Ha, J-S, Do, Y R, Ki, C-S, Lee, C, Kim, D-H, Lee, W, Ryoo, N-H, Jeon, D-S

Volltext

Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality von Fuji, S, Mori, T, Khattry, N, Cheng, J, Do, Y R, Yakushijin, K, Kohashi, S, Fukuda, T, Kim, S-W

Volltext

A MULTI‐CENTER RETROSPECTIVE STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NK/T‐CELL LYMPHOMA von Lee, J. Y., Kwon, J. H., Hur, J. Y., Yoon, D. H., Do, Y. R., Jo, J., Kang, H. J., Koh, Y., Lee, W. S., Lim, S., Lee, J.

Volltext

Excellent color rendering indexes of multi-package white LEDs von Oh, Ji Hye, Yang, Su Ji, Sung, Yeon-Goog, Do, Y R

Volltext

Ibrutinib in Combination with Ifosfamide, Etoposide, and Rituximab Followed by Ibrutinib Maintenance Therapy in Patients with R/R‐PCNSL: A Multicenter Phase II Study von Choi, Y. S., Song, G., Baek, D. W., Yoon, S. E., Kang, K., Yhim, H., Oh, S. Y., Jeong, S. H., Kim, S. J., Kim, H. J., Do, Y. R., Yang, D.

Volltext

SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA: LONGER FOLLOW‐UP FROM THE PIVOTAL EPCORE NHL‐1 TRIAL von Thieblemont, C., Karimi, Y., Jurczak, W., Cheah, C. Y., Clausen, M. R., Cunningham, D., Do, Y. R., Lewis, D. J., Gasiorowski, R., Kim, T. M., Poel, M., Poon, M. L., Feldman, T., Linton, K. M., Sureda, A., Hutchings, M., Cottereau, A., Al Tabaa, Y., Stirner, M. Cota, Liu, Y., Kilavuz, N., Sacchi, M., Lugtenburg, P., Ghesquieres, H.

Volltext

TREATMENT PATTERNS IN PATIENTS WITH MANTLE CELL LYMPHOMA: UPDATED REPORT OF THE ASIA‐PACIFIC MULTINATIONAL RETROSPECTIVE REGISTRY STUDY von Kim, W. S., Yoon, D. H., Cho, H., Chan, J. Y., Kim, D. J., Kang, K., Kwak, J., Tan, S., Lee, J., Oh, S. Y., Do, Y. R., Eom, H., Jeong, S. H., Kang, H. J., Koh, Y., Bunworasate, U., Kim, H. J., Jo, J., Kim, S., Won, J. H., Park, Y. H., Chan, E., Lin, T., Chen, T., Yang, D. H., Kato, K., Cai, Q., Ng, S. C.

Volltext

PROGNOSTIC SIGNIFICANCE OF SEQUENTIAL 18F‐FDG PET/CT DURING THE TREATMENT OF ANTHRACYCLINE‐CONTAINING FRONTLINE CHEMOTHERAPY IN PERIPHERAL T CELL LYMPHOMAS von Song, G., Jung, S., Ahn, S., Kim, M., Ahn, J., Lee, J., Kim, H., Do, Y. R., Moon, J. B., Yoo, S. W., Kwon, S. Y., Min, J., Bom, H., Kang, S., Yang, D.

Volltext

Combination of acalabrutinib with rituximab and lenalidomide in relapsed/refractory B cell non‐Hodgkin lymphoma von Park, C., Lee, H. S., Kang, K., Lee, W., Do, Y. R., Kwak, J., Shin, H., Kim, S., Yi, J. H., Lim, S. N., Lee, J., Yang, D., Byun, J. M., Yoon, S., Koh, Y.

Volltext

9-year follow-up bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for pa... von Lee, E, Lee, H, Lee, J.-J, Chung, J.-S, Kim, K, Kim, H.J, Kim, H.Y, Jin, J.-Y, Do, Y.-R, Oh, S.-J, Suh, C, Seong, C.-M, Kim, C.S, Lee, D.S, Lee, J.H, Eom, H.-S

Volltext

A randomized phase II trial of CHOP versus ICED and autologous stem cell transplantation in newly diagnosed T‐cell lymphoma von Yoo, K. H., Kim, S. J., Jo, J., Yoon, D. H., Yang, D., Yoon, S. E., Lee, G., Park, Y., Kang, K., Lee, H., Oh, S. Y., Shin, H., Kang, H. J., Lee, W. S., Choi, Y. S., Jeong, S. H., Kim, M. K., Yi, J. H., Lim, S., Yhim, H., Do, Y. R., Yun, W. J., Eom, H., Lee, M. H., Kong, J. H., Suh, C., Kim, W. S.

Volltext

Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma von Yi, J. H., Kim, S. J., Yang, D., Do, Y. R., Won, J. H., Baek, D., Shin, H. J., Kim, D. S., Kim, H. J., Kang, K., BAE, S. H., Kwon, J., Kwon, J. H., Kim, W. S.

Volltext

PROSPECTIVE KOREAN MARGINAL ZONE LYMPHOMAS COHORT STUDY: INITIAL DATA ANALYSIS OF 407 CASES von OH, S.Y., Park, Y., Lim, S., Jo, J., Sohn, B. S., Kim, S. J., Kim, W. S., Kim, H. J., Won, J. H., Jung, K. S., Chang, M. H., Eom, H., Sung, H., Lee, H. S., Do, Y. R., Kang, H. J., Yhim, H., Park, B., Lee, J. H., Lee, J. H., Lee, W. S., Jeong, S. H., Yoon, D. H., Suh, C.

Volltext

Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group von Kim, J G, Sohn, S K, Chae, Y S, Song, H S, Kwon, K-Y, Do, Y R, Kim, M K, Lee, K H, Hyun, M S, Ryoo, H M, Bae, S H, Park, K U, Lee, W S, Baek, J H, Chung, H Y, Yu, W

Volltext

Enhanced Light Extraction from Organic Light-Emitting Diodes with 2D SiO2/SiNx Photonic Crystals von Do, Y.R., Kim, Y.C., Song, Y.-W., Cho, C.-O, Jeon, H., Lee, Y.-J., Kim, S.-H., Lee, Y.-H.

Volltext

Photoluminescence properties of red emitting BaGdB9O16 :Eu phosphor von PARK, W, SUMMERS, C. J, DO, Y. R, YANG, H. G

Volltext

Application of photoluminescence phosphors to a phosphor-liquid crystal display von Do, Y. R., Bae, J. W.

Volltext